Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 80, 2020 - Issue 8
Submit an article Journal homepage
288
Views
3
CrossRef citations to date
0
Altmetric
Technical Note

Thrombophilia testing in patients with portal vein thrombosis

Malene Helligsø Kirkebya Thrombosis and Haemostasis Research Unit, Department of Clinical Biochemistry, Aarhus University Hospital, DenmarkORCID Iconhttps://orcid.org/0000-0002-7890-5948
ORCID Icon,
Julie Brogaard Larsena Thrombosis and Haemostasis Research Unit, Department of Clinical Biochemistry, Aarhus University Hospital, DenmarkORCID Iconhttps://orcid.org/0000-0002-2978-5185
ORCID Icon,
Henning Grønbaekb Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark;c Department of Clinical Medicine, Aarhus University, Aarhus, DenmarkORCID Iconhttps://orcid.org/0000-0001-8998-7910
ORCID Icon &
Anne-Mette Hvasc Department of Clinical Medicine, Aarhus University, Aarhus, DenmarkCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7136-7534
ORCID Icon
Pages 694-698 | Received 03 Feb 2020, Accepted 19 Sep 2020, Published online: 07 Oct 2020

References

  • Ponziani FR, Zocco MA, Campanale C, et al. Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World J Gastroenterol. 2010;16(2):143–155.
  • Sogaard KK, Darvalics B, Horvath-Puho E, et al. Survival after splanchnic vein thrombosis: a 20-year nationwide cohort study. Thromb Res. 2016;141:1–7.
  • Almdal TP, Sorensen TI. Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: analysis of hospitalization registry data. The Danish Association for the Study of the Liver. Hepatology. 1991;13(4):650–655.
  • Klute K, DeFilippis EM, Shillingford K, et al. Clinical presentations, risk factors, treatment and outcomes in patients with splanchnic vein thrombosis: a single-center experience. J Thromb Thrombolysis. 2016;42(2):267–271.
  • Yonal I, Pinarbasi B, Hindilerden F, et al. The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis. J Thromb Thrombolysis. 2012;34(3):388–396.
  • Janssen HL, Meinardi JR, Vleggaar FP, et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood. 2000;96(7):2364–2368.
  • Dentali F, Galli M, Gianni M, et al. Inherited thrombophilic abnormalities and risk of portal vein thrombosis. a meta-analysis. Thromb Haemost. 2008;99(4):675–682.
  • Qi X, De Stefano V, Su C, et al. Associations of antiphospholipid antibodies with splanchnic vein thrombosis: a systematic review with meta-analysis. Medicine (Baltimore). 2015;94(4):e496.
  • Qi X, Ren W, De Stefano V, et al. Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12(11):1801–1812.e7.
  • Sode BF, Allin KH, Dahl M, et al. Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type. Can Med Assoc J . 2013;185(5):E229–E237.
  • Mahmoodi BK, Brouwer JL, Ten Kate MK, et al. A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin. J Thromb Haemost. 2010;8(6):1193–1200.
  • Urbanus RT, Siegerink B, Roest M, et al. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol. 2009;8(11):998–1005.
  • Romero Gomez M, Suarez Garcia E, Lopez Lacomba D, et al. Antiphospholipid antibodies are related to portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol. 2000;31:237–240.
  • Amitrano L, Ames PR, Guardascione MA, et al. Antiphospholipid antibodies and antiphospholipid syndrome: role in portal vein thrombosis in patients with and without liver cirrhosis. Clin Appl Thromb Hemost. 2011;17(4):367–370.
  • Bergrem A, Dahm AE, Jacobsen AF, et al. Differential haemostatic risk factors for pregnancy-related deep-vein thrombosis and pulmonary embolism: a population-based case-control study. Thromb Haemost. 2012;108(6):1165–1171.
  • de Galan-Roosen AE, Kuijpers JC, Rosendaal FR, et al. Maternal and paternal thrombophilia: risk factors for perinatal mortality. BJOG. 2005;112(3):306–311.
  • Tektonidou MG, Andreoli L, Limper M, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis. 2019;78(10):1296–1304.
  • Tremblay D, Naymagon L, Troy K, et al. The utility of thrombophilia testing in patients with newly diagnosed portal vein thrombosis. Blood Coagul Fibrinolysis. 2020;31(3):213–218.
  • Dansk selskab for Trombose og Haemostase. Retningslinje om udredning for trombofili; 2013. Available from: https://www.dsth.dk/pdf/Rapporter_retningslinjer/01_TROMBOFILI.pdf.
  • Baglin T, Gray E, Greaves M, British Committee for Standards in Haematology, et al. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol. 2010;149(2):209–220.
  • Priyanka P, Kupec JT, Krafft M, et al. Newer oral anticoagulants in the treatment of acute portal vein thrombosis in patients with and without cirrhosis. Int J Hepatol. 2018;2018:8432781.
  • Naymagon L, Tremblay D, Zubizarreta N, et al. The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis. Blood Adv. 2020;4(4):655–666.
  • Joshi A, Hong J, Siva C. Recurrent thrombosis in patients with antiphospholipid syndrome receiving newer oral anticoagulants: a case report and review of literature. Clin Med Res. 2017;15(1-2):41–44.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.